OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.540
+0.100 (6.94%)
Jul 22, 2026, 11:43 AM EDT - Market open
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $80.82 million as of July 22, 2026. Its market cap has decreased by -23.80% in one year.
Market Cap
80.82M
Enterprise Value
54.98M
1-Year Change
-23.80%
Ranking
Category
Stock Price
$1.54
ChartMarket Cap Chart
Since the IPO on May 17, 2022, OKYO Pharma's market cap has decreased from $86.61M to $80.82M, a decrease of -6.69%. That is a compound annual growth rate of -1.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 80.82M | 3.81% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -50.99% |
| May 17, 2022 | 86.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 74.69M |
| Enlivex | 74.56M |
| Acrivon Therapeutics | 74.48M |
| Annovis Bio | 71.90M |
| LeonaBio | 71.11M |
| MindWalk Holdings | 71.02M |
| Gain Therapeutics | 69.53M |
| Gossamer Bio | 68.93M |